These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3784897)

  • 1. Gd(DOTA): an alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy.
    Magerstädt M; Gansow OA; Brechbiel MW; Colcher D; Baltzer L; Knop RH; Girton ME; Naegele M
    Magn Reson Med; 1986 Oct; 3(5):808-12. PubMed ID: 3784897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
    Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
    Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
    Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-DOTA enhanced MR imaging of intracranial lesions.
    Parizel PM; Degryse HR; Gheuens J; Martin JJ; Van Vyve M; De La Porte C; Selosse P; Van de Heyning P; De Schepper AM
    J Comput Assist Tomogr; 1989; 13(3):378-85. PubMed ID: 2723166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-DOTA: characterization of a new paramagnetic complex.
    Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
    Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic field dependence of solvent proton relaxation rates induced by Gd3+ and Mn2+ complexes of various polyaza macrocyclic ligands: implications for NMR imaging.
    Geraldes CF; Sherry AD; Brown RD; Koenig SH
    Magn Reson Med; 1986 Apr; 3(2):242-50. PubMed ID: 3086656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation.
    Braunschweiger PG; Schiffer L; Furmanski P
    Magn Reson Imaging; 1986; 4(4):285-91. PubMed ID: 3118123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of polyaza macrocyclic methylene phosphonate chelates of Gd3+ ions as MRI contrast agents.
    Geraldes CF; Brown RD; Cacheris WP; Koenig SH; Sherry AD; Spiller M
    Magn Reson Med; 1989 Jan; 9(1):94-104. PubMed ID: 2540397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
    Nwe K; Bernardo M; Regino CA; Williams M; Brechbiel MW
    Bioorg Med Chem; 2010 Aug; 18(16):5925-31. PubMed ID: 20663676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gd-25 DTPA-MAb, a potential NMR contrast agent for MRI in the xenografted nude mouse: preliminary studies.
    Curtet C; Bourgoin C; Bohy J; Saccavini JC; Thédrez P; Akoka S; Tellier C; Chatal JF
    Int J Cancer Suppl; 1988; 2():126-32. PubMed ID: 3280506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis neutral rare earth complexes of diethylenetriamine-N,N''-bis(acetyl-isoniazid)-N,N',N''-triacetic acid as potential contrast enhancement agents for magnetic resonance imaging.
    Zhang DW; Yang ZY; Wang BD; Zhang SP; Yang RD
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1203-6. PubMed ID: 16880671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents.
    Chan KW; Barra S; Botta M; Wong WT
    J Inorg Biochem; 2004 May; 98(5):677-82. PubMed ID: 15134912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
    Wedeking P; Tweedle M
    Int J Rad Appl Instrum B; 1988; 15(4):395-402. PubMed ID: 3255735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet and magnetic-circular-dichroic spectroscopic studies of Gd(III) complexed with diethylenetriaminepentaacetic acid. A contrast agent for NMR imaging.
    Bligh SW; Drake AF; Sadler PJ
    Eur J Biochem; 1989 Apr; 181(1):223-4. PubMed ID: 2714280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
    Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
    Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.